Clinical Trials Update: Nov. 3, 2006
Testotoxicosis Hypertension (High Blood Pressure) Non-Small Cell Lung Cancer
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Testotoxicosis is a condition that causes early puberty in boys, with symptoms including growth spurts, and early development of muscles and sexual organs. Boys aged 2 years or older with a clinical diagnosis of testotoxicosis who have a bone age of 10 years or less and no prior treatment with a class of drugs called "antiandrogens" may be included.
The research sites are located in the United States, Germany, and the United Kingdom.
Hypertension (High Blood Pressure)
This research study will evaluate the effectiveness of an investigational medication in combination with an approved medication to treat high blood pressure. Risk factors for high blood pressure include high cholesterol, diabetes, smoking, and being overweight. Candidates at least 18 who have known or suspected high blood pressure may qualify.
The research site is in Salt Lake City, Utah.
Non-Small Cell Lung Cancer
This study will compare the effectiveness of Tarceva vs. placebo following complete surgical removal of a stage IB-IIIA non-small cell lung cancer (NSCLC) tumor that is EGFR-positive. Volunteers will not be accepted who have carcinoid tumors, or tumors with mixed histology of NSCLC and SCLC.
The research sites are located across the United States.
Copyright 2006 Thomson CenterWatch. All rights reserved.